Suntrust Banks’s IGC Pharma IGC Stock Holding History

Suntrust Banks’s Portfolio IGC Stock Details IGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$36K	Hold	36,667	–	–	﹤0.01%	1315
2019 Q2	$60K	Hold	36,667	–	–	﹤0.01%	1303
2019 Q1	$76K	Buy	+36,667	New	+$83.3K	﹤0.01%	1271
2018 Q4	–	Sell	-55,000	Closed	-$355K	–	1308
2018 Q3	$355K	Hold	55,000	–	–	﹤0.01%	1023
2018 Q2	$27K	Hold	55,000	–	–	﹤0.01%	1306
2018 Q1	$31K	Hold	55,000	–	–	﹤0.01%	1281
2017 Q4	$55K	Buy	+55,000	New	+$30.4K	﹤0.01%	1217

Other funds holding IGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFA

Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return

Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Suntrust Banks's IGC Position: Q3 2019 in Review

Suntrust Banks held its IGC Pharma (IGC) position steady in Q3 2019 at 36,667 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1315.

Suntrust Banks first reported a position in IGC in Q4 2017 and has held it in 7 quarters since. The position peaked at $355K in Q3 2018. 26 funds tracked by Wall St. Rank hold IGC as of Q3 2019.

Suntrust Banks held 36,667 shares of IGC Pharma worth $36K as of Q3 2019.
Suntrust Banks left its IGC Pharma share count unchanged in Q3 2019.
IGC Pharma made up ﹤0.01% of Suntrust Banks's portfolio in Q3 2019, its #1315 holding.
Suntrust Banks first reported a position in IGC Pharma in Q4 2017 and has held it in 7 quarters since.
Suntrust Banks's IGC Pharma position peaked at $355K in Q3 2018.
26 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.